A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
Clinical trial NCT01704495 · COMPLETED
Trial details
- NCT number
- NCT01704495
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-08-01
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.